Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-000151

CEO and CFO bought 2,400 shares at $11.36 ($27,264)

From the SEC's structured data for this filing

Trades in this filing

Patel Snehal · CEO and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-31 Purchase : show line 1 in the form +2,400 $11.36 $27,264 5,541,702 D
Open-market purchases · 2,400 sh · avg $11.36 · $27,264
Loading xslF345X05/ownership.xml…